Evidence map›Paper›PMID 20029693›Full record

ArticleSheng li xue bao : [Acta physiologica Sinica]2009

A novel insight into neuroprotection against hypoxic/ischemic stress.

Yuan Feng, Dongman Chao, Xiaozhou He, Yilin Yang, Xuezhi Kang, Lawrence H Lazarus, Ying Xia

Open access · greenAbstract read
In one paragraph

Article in Sheng li xue bao : [Acta physiologica Sinica], 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. The delta-opioid receptor and Parkinson's disease.CNS neuroscience & therapeutics · 2018
    Review
  6. Article
  7. Article
  8. Delta opioid receptor and its peptide: a receptor-ligand neuroprotection.International journal of molecular sciences · 2013
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yuan FengYale University School of Medicine, New Haven, CT 06520, USA.
Dongman Chao
Xiaozhou He
Yilin Yang
Xuezhi Kang
Lawrence H Lazarus
Ying Xia
Yale University · US

Funding

Hypoxia &Neuronal Excitability: Cellular MechanismsR01HD034852 · NICHD · YALE UNIVERSITY · PI XIA, YING · 1997 to 2012
$3.5M
A new strategy for protection from cerebral ischemiaR01AT004422 · NCCIH · YALE UNIVERSITY · PI XIA, YING · 2009 to 2013
$1.9M
Intramural NIH HHSNCCIH NIH HHS AT004422NCCIH NIH HHS R01 AT004422NCI NIH HHS 2006CB504509NICHD NIH HHS HD034852NICHD NIH HHS R01 HD034852PHS HHS 05DZ19745PHS HHS 0755993T
6 · The paper itself

Abstract

The use of opioid analgesics has a long history in clinical settings, although the functions of opioid receptors, especially their role in the brain, are not well understood yet. Recent studies have generated abundant new data on opioid receptor-mediated functions and the underlying mechanisms. The most exciting finding in the past decade is probably the neuroprotection against hypoxic/ischemic stress mediated by delta-opioid receptors (DOR). An up-regulation of DOR expression and the release of endogenous opioids may increase neuronal tolerance to hypoxic/ischemic stress. The DOR signal triggers, depending on stress duration and severity, different mechanisms at multiple levels to preserve neuronal survival, including the stabilization of ionic homeostasis, an increase in pro-survival signaling (e.g., PKC-ERK-Bcl 2) and the enhanced anti-oxidative capacity. Recent data on DOR-mediated neuroprotection provide us a new concept of neuroprotection against neurological disorders and have a potentially significant impact on the prevention and treatment of some serious neurological conditions, such as stroke.

Indexed as

Analgesics, OpioidHumansHypoxiaNeuronsNeuroprotective AgentsReceptors, Opioid, deltaSignal TransductionAnalgesics, OpioidNeuroprotective AgentsReceptors, Opioid, delta

Identifiers

PMID20029693
PMCPMC3034294
OpenAlexW148610591

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.